INCREASING LIFE EXPECTANCY: IMPLICATIONS FOR COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Majer, I. M. [1 ]
Heeg, B. [1 ]
机构：
[1] Pharmerit Int, Rotterdam, Zuid Holland, Netherlands
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1508
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A468 / A468
页数：1
相关论文
共 50 条
  • [1] DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?
    Paulden, M.
    Culyer, A. J.
    VALUE IN HEALTH, 2011, 14 (03) : A12 - A12
  • [2] COST-EFFECTIVENESS ANALYSIS - IMPLICATIONS FOR ACCOUNTANTS
    KING, BG
    JOURNAL OF ACCOUNTANCY, 1970, 129 (03): : 43 - 49
  • [3] Cost-effectiveness analysis: role and implications
    Marsden, G.
    Wonderling, D.
    PHLEBOLOGY, 2013, 28 : 135 - 140
  • [4] IMPLICATIONS FOR COST-EFFECTIVENESS
    CALIFF, RM
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (16): : 1182 - 1182
  • [5] IMPLICATIONS FOR COST-EFFECTIVENESS
    GRAFF, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (14): : 1039 - 1039
  • [6] Implications for cost-effectiveness
    Glasser, SP
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (01): : 85 - 85
  • [7] Implications for cost-effectiveness
    Michael, TAD
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (02): : 190 - 190
  • [8] IMPLICATIONS FOR COST-EFFECTIVENESS
    HARRINGTON, RA
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17): : 1227 - 1227
  • [9] IMPLICATIONS FOR COST-EFFECTIVENESS
    BAHLER, RC
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (12): : 891 - 891
  • [10] Cost-Effectiveness of Oral Bisphosphonates for Osteoporosis at Different Ages and Levels of Life Expectancy
    Pham, Annalise N.
    Datta, Santanu K.
    Weber, Thomas J.
    Walter, Louise C.
    Colon-Emeric, Cathleen S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (09) : 1642 - 1649
12345